IMR Press / FBL / Volume 13 / Issue 6 / DOI: 10.2741/2824

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Role of dendritic cells and chemokines in acute graft-versus-host disease
Show Less
1 Shanghai Institute of Immunology and Institute of Health Sciences, Shanghai Jiao Tong University School of Medicine and Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 227 South Chongqing Road, Shanghai 200025, China
2 Department of Nephrology, Rui Jin hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Er road, Shanghai 200025, China

*Author to whom correspondence should be addressed.

 

Front. Biosci. (Landmark Ed) 2008, 13(6), 2065–2074; https://doi.org/10.2741/2824
Published: 1 January 2008
Abstract

Graft-versus-host disease (GVHD) is a major complication of allogeneic bone marrow transplantation. GVHD is caused by donor T cells that recognize and react to recipient histocompatibility differences, resulting in significant morbidity and mortality. The pathophysiology of GVHD is complex, which occurs in three phases: induction phase, activation phase and effector phase. Numerous studies have demonstrated that GVHD involves multiple inflammatory cells and cytokines, in particular of antigen presenting cells, chemokines and T cell subsets. This review will discuss roles of a special antigen presenting cell: dendritic cell and chemokines in T cell-mediated acute GVHD.

Share
Back to top